REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis

NCT06788535 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

204

Enrollment

OTHER

Sponsor class

Conditions

Cardiac Amyloidosis

Interventions

DRUG: I-124 evuzamitide

Sponsor

Sharmila Dorbala

Collaborators

[object Object]